Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03618953
Title This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers (Kingfisher)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Turnstone Biologics, Inc.
Indications

vaginal cancer

cervical cancer

penile cancer

anal canal cancer

vulva cancer

oropharynx cancer

Therapies

Ad-E6E7 + Atezolizumab + MG1-E6E7

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.